Biohaven Ltd (NYSE: BHVN) kicked off on Monday, down -13.66% from the previous trading day, before settling in for the closing price of $17.2. Over the past 52 weeks, BHVN has traded in a range of $12.79-$54.98.
A company in the Healthcare sector has dropped its sales by -49.78% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 17.68%. With a float of $92.38 million, this company’s outstanding shares have now reached $105.78 million.
Biohaven Ltd (BHVN) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Biohaven Ltd is 12.68%, while institutional ownership is 76.91%. The most recent insider transaction that took place on Mar 04 ’25, was worth 996,238. In this transaction Director of this company bought 32,700 shares at a rate of $30.47, taking the stock ownership to the 2,320,571 shares. Before that another transaction happened on Dec 30 ’24, when Company’s Director bought 29,000 for $35.94, making the entire transaction worth $1,042,393. This insider now owns 2,368,741 shares in total.
Biohaven Ltd (BHVN) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -1.74 earnings per share (EPS), lower than consensus estimate (set at -1.55) by -0.19. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.99% during the next five years compared to -49.78% drop over the previous five years of trading.
Biohaven Ltd (NYSE: BHVN) Trading Performance Indicators
Take a look at Biohaven Ltd’s (BHVN) current performance indicators. Last quarter, stock had a quick ratio of 3.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.66, a number that is poised to hit -1.88 in the next quarter and is forecasted to reach -5.97 in one year’s time.
Technical Analysis of Biohaven Ltd (BHVN)
Let’s dig in a bit further. During the last 5-days, its volume was 2.57 million. That was better than the volume of 1.85 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 33.15%.
During the past 100 days, Biohaven Ltd’s (BHVN) raw stochastic average was set at 35.67%, which indicates a significant increase from 10.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.18 in the past 14 days, which was higher than the 0.93 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.58, while its 200-day Moving Average is $20.86. However, in the short run, Biohaven Ltd’s stock first resistance to watch stands at $16.06. Second resistance stands at $17.26. The third major resistance level sits at $18.08. If the price goes on to break the first support level at $14.04, it is likely to go to the next support level at $13.22. Assuming the price breaks the second support level, the third support level stands at $12.02.
Biohaven Ltd (NYSE: BHVN) Key Stats
The company with the Market Capitalisation of 1.57 billion has total of 105,791K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -846,420 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -198,150 K.
